Royalty Pharma RPRX
NASDAQ RPRX
$57.78 +0.15 (+0.26%)
As of: Oct 2, 2026 · 10:04 AM EDT

Royalty Pharma (RPRX) Net Equity Issued and Repurchased (2020)

Updated

Royalty Pharma's Net Equity Issued and Repurchased came in at -$907,000 for Q4 2020.

Analysis

Royalty Pharma (RPRX) Net Equity Issued and Repurchased (2020) Analysis & Trends

For FY2020, Royalty Pharma's Net Equity Issued and Repurchased was $1.91 billion.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Rocket Companies 43.26 Bn 28.94 Bn - 15.00 Mn
2 Orix 42.40 Bn 42.90 Bn - -
3 Royalty Pharma 33.56 Bn 33.47 Bn - -
4 Federal National Mortgage Association Fannie Mae 24.47 Bn 24.47 Bn - -
5 Affirm Holdings 23.34 Bn 17.03 Bn - -
6 Synchrony Financial 23.06 Bn -44.91 Bn - -
7 Royal Gold 19.98 Bn 19.21 Bn 390.45 Mn 2.48 Mn
8 Annaly Capital Management 14.18 Bn 5.27 Bn - 447.00 Mn
9 Ares Capital 13.71 Bn 11.15 Bn - -
10 Federal Home Loan Mortgage 12.39 Bn -6.35 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -907,000.00
Sep 30, 2020 -8.58 Mn
API Access

Royalty Pharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RPRX&period=max&api_key=YOUR_API_KEY